These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7989778)

  • 1. The carboxyl-terminal region of HIV-1 Nef protein is a cell surface domain that can interact with CD4+ T cells.
    Otake K; Fujii Y; Nakaya T; Nishino Y; Zhong Q; Fujinaga K; Kameoka M; Ohki K; Ikuta K
    J Immunol; 1994 Dec; 153(12):5826-37. PubMed ID: 7989778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Nef protein regulates productive HIV-1 infection from latency.
    Fujinaga K; Zhong Q; Nakaya T; Kameoka M; Meguro T; Yamada K; Ikuta K
    J Immunol; 1995 Dec; 155(11):5289-98. PubMed ID: 7594542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nef 27, but not the Nef 25 isoform of human immunodeficiency virus-type 1 pNL4.3 down-regulates surface CD4 and IL-2R expression in peripheral blood mononuclear cells and transformed T cells.
    Greenway AL; McPhee DA; Grgacic E; Hewish D; Lucantoni A; Macreadie I; Azad A
    Virology; 1994 Jan; 198(1):245-56. PubMed ID: 7903128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1.
    Keppler OT; Tibroni N; Venzke S; Rauch S; Fackler OT
    J Leukoc Biol; 2006 Mar; 79(3):616-27. PubMed ID: 16365153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.
    Priceputu E; Hanna Z; Hu C; Simard MC; Vincent P; Wildum S; Schindler M; Kirchhoff F; Jolicoeur P
    J Virol; 2007 May; 81(9):4677-93. PubMed ID: 17314161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 Nef mediates post-translational down-regulation and redistribution of the mannose receptor.
    Vigerust DJ; Egan BS; Shepherd VL
    J Leukoc Biol; 2005 Apr; 77(4):522-34. PubMed ID: 15637102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Nef-induced CD4 T cell proliferation.
    Torres BA; Tanabe T; Johnson HM
    Biochem Biophys Res Commun; 1996 Aug; 225(1):54-61. PubMed ID: 8769094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane.
    Burtey A; Rappoport JZ; Bouchet J; Basmaciogullari S; Guatelli J; Simon SM; Benichou S; Benmerah A
    Traffic; 2007 Jan; 8(1):61-76. PubMed ID: 17140399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open.
    Foster JL; Anderson SJ; Frazier AL; Garcia JV
    Virology; 1994 Jun; 201(2):373-9. PubMed ID: 8184546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
    Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
    Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epitope mapping of murine monoclonal antibodies against human immunodeficiency virus type 1 Nef.
    Otake K; Fujii Y; Tashiro M; Adachi A; Kitoh J
    Exp Anim; 1997 Jan; 46(1):53-8. PubMed ID: 9027472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
    Hanna Z; Priceputu E; Kay DG; Poudrier J; Chrobak P; Jolicoeur P
    Virology; 2004 Oct; 327(2):273-86. PubMed ID: 15351215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells?
    Azad AA
    Biochem Biophys Res Commun; 2000 Jan; 267(3):677-85. PubMed ID: 10673351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
    Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
    Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of human immunodeficiency virus type 1 Nef antigen on the surface of acutely and persistently infected human T cells.
    Fujii Y; Nishino Y; Nakaya T; Tokunaga K; Ikuta K
    Vaccine; 1993 Sep; 11(12):1240-6. PubMed ID: 8256505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.
    Hanna Z; Priceputu E; Hu C; Vincent P; Jolicoeur P
    Virology; 2006 Mar; 346(1):40-52. PubMed ID: 16310238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.
    Collins KL; Chen BK; Kalams SA; Walker BD; Baltimore D
    Nature; 1998 Jan; 391(6665):397-401. PubMed ID: 9450757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement.
    Rhee SS; Marsh JW
    J Immunol; 1994 May; 152(10):5128-34. PubMed ID: 8176229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.